ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

ACHV Achieve Life Sciences Inc

4,90
-0,19 (-3,73%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Achieve Life Sciences Inc ACHV NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,19 -3,73% 4,90 06:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,06 4,80 5,07 4,90 5,09
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/6/202423:07EDGAR2Form 8-K - Current report
29/5/202414:00GLOBEAchieve Life Sciences Announces Initiation of ORCA-OL..
20/5/202423:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/5/202420:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17/5/202414:00GLOBEAchieve Life Sciences Announces Data from Cytisinicline..
09/5/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:01GLOBEAchieve Life Sciences Reports Financial Results for First..
07/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/5/202417:16GLOBEAchieve Life Sciences Announces Publication of Cytisinicline..
25/4/202414:00GLOBEAchieve Life Sciences to Announce First Quarter Financial..
11/4/202414:00GLOBEAchieve Life Sciences to Present at Life Science Innovation..
28/3/202421:01GLOBEAchieve Life Sciences Reports Financial Results for Fourth..
20/3/202413:00GLOBEAchieve Life Sciences Announces Data from Cytisinicline ORCA..
14/3/202413:00GLOBEAchieve Life Sciences to Announce Fourth Quarter and..
06/3/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:41EDGAR2Form 8-K - Current report
29/2/202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202414:01GLOBEAchieve Life Sciences Reaches Agreement with the FDA on..
29/2/202414:00GLOBEAchieve Life Sciences Announces Pricing of up to $124.2..
27/2/202421:32EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/1/202420:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202322:04EDGAR2Form 8-K - Current report
09/11/202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:00GLOBEAchieve Life Sciences Reports Financial Results for Third..
26/10/202314:00GLOBEAchieve Life Sciences to Announce Third Quarter 2023..
03/10/202314:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
11/9/202314:00GLOBEAchieve Life Sciences Announces Presentation of..
07/9/202314:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
14/8/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:06EDGAR2Form 8-K - Current report
14/8/202322:00GLOBEAchieve Life Sciences Reports Financial Results for Second..
01/8/202314:00GLOBEAchieve Life Sciences to Announce Second Quarter 2023..
18/7/202314:00GLOBEAchieve Life Sciences Announces Presentation at 2023..
11/7/202317:23GLOBEAchieve Life Sciences Announces Publication of Cytisinicline..

Dernières Valeurs Consultées

Delayed Upgrade Clock